Isabelle L. Ryden

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Relationship between functional network integrity, cognition and fatigue at long-term follow-up in patients with IDH-mutated gliomas.

Relationship between functional network integrity, cognition and fatigue at long-term follow-up in patients with IDH-mutated gliomas.

Journal: Frontiers in human neuroscience

Published: April 20, 2026

Genetic Risk Factors for Poor Cognitive Outcome Following Brain Insult-A Systematic Review.

Genetic Risk Factors for Poor Cognitive Outcome Following Brain Insult-A Systematic Review.

Journal: Brain and behavior

Published: December 31, 2025

Targeting IDH mutation: another milestone, but not the finish line.

Targeting IDH mutation: another milestone, but not the finish line.

Journal: The Lancet. Oncology

Published: August 11, 2025

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.

Journal: Neuro-oncology

Published: July 22, 2025

Reliable cognitive changes the first year following guideline-based treatment of IDH mutated gliomas: a longitudinal multicenter study.

Reliable cognitive changes the first year following guideline-based treatment of IDH mutated gliomas: a longitudinal multicenter study.

Journal: Neuro-oncology

Published: June 26, 2025

Reliable cognitive changes the first year following guideline-based treatment of isocitrate dehydrogenase mutated gliomas: A longitudinal multicenter study.

Reliable cognitive changes the first year following guideline-based treatment of isocitrate dehydrogenase mutated gliomas: A longitudinal multicenter study.

Journal: Neuro-oncology

Published: June 26, 2025

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigation.

Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigation.

Journal: Neuro-oncology

Published: March 24, 2025

Mental fatigue and cognitive functioning in patients presenting with non-enhancing gliomas.

Mental fatigue and cognitive functioning in patients presenting with non-enhancing gliomas.

Journal: Acta neurochirurgica

Published: October 02, 2024

Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.

Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.

Journal: Neuro-oncology practice

Published: July 15, 2024

Global health status and fatigue score in isocitrate dehydrogenase-mutant diffuse glioma grades 2 and 3: A longitudinal population-based study from surgery to 12-month follow-up.

Global health status and fatigue score in isocitrate dehydrogenase-mutant diffuse glioma grades 2 and 3: A longitudinal population-based study from surgery to 12-month follow-up.

Journal: Neuro-oncology practice

Published: May 13, 2024

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Journal: BMJ open

Published: March 20, 2023

Seizures in patients with IDH-mutated lower grade gliomas.

Seizures in patients with IDH-mutated lower grade gliomas.

Journal: Journal of neuro-oncology

Published: September 14, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026